Caveolin-1 Expression Is Critical for Vascular Endothelial Growth Factor–Induced Ischemic Hindlimb Collateralization and Nitric Oxide–Mediated Angiogenesis
暂无分享,去创建一个
Jean-Luc Balligand | Vincent Grégoire | Chantal Dessy | Pierre Sonveaux | Philippe Martinive | V. Grégoire | J. Balligand | C. Dessy | M. Pelat | P. Ghisdal | G. Daneau | P. Martinive | P. Sonveaux | Olivier Feron | Julie DeWever | Zuzana Batova | Géraldine Daneau | Michel Pelat | Philippe Ghisdal | Julie Dewever | Z. Báťová | O. Féron
[1] A. Y. Wu,et al. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. , 1999, Circulation research.
[2] K. Iwatsubo,et al. Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. , 2001, Cardiovascular research.
[3] J. Balligand,et al. Hsp90 and Caveolin Are Key Targets for the Proangiogenic Nitric Oxide–Mediated Effects of Statins , 2001, Circulation research.
[4] David S. Park,et al. Caveolin-1 Expression Enhances Endothelial Capillary Tubule Formation* , 2002, The Journal of Biological Chemistry.
[5] M. Drab,et al. Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice , 2001, Science.
[6] G. Garcı́a-Cardeña,et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.
[7] I. Yuhanna,et al. Oxidized Low Density Lipoprotein Displaces Endothelial Nitric-oxide Synthase (eNOS) from Plasmalemmal Caveolae and Impairs eNOS Activation* , 1999, The Journal of Biological Chemistry.
[8] J. Engelman,et al. Caveolin‐mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo , 1998, FEBS letters.
[9] K. Sandvig,et al. Caveolae: anchored, multifunctional platforms in the lipid ocean. , 2003, Trends in cell biology.
[10] J. Balligand,et al. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. , 1999, The Journal of clinical investigation.
[11] S. Woodman,et al. Caveolin-1 knockout mice show an impaired angiogenic response to exogenous stimuli. , 2003, The American journal of pathology.
[12] G. Christ,et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. , 2001, The Journal of biological chemistry.
[13] S. Vatner,et al. Downregulation of caveolin by chronic β-adrenergic receptor stimulation in mice. , 1997, American journal of physiology. Cell physiology.
[14] D. Kass,et al. Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. , 2000, Circulation research.
[15] O. Frazier,et al. Mechanical unloading increases caveolin expression in the failing human heart. , 2003, Cardiovascular research.
[16] J. Balligand,et al. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. , 2003, Cardiovascular research.
[17] R. Kelly,et al. The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. , 2001, Circulation research.
[18] S. Woodman,et al. Caveolae: From Cell Biology to Animal Physiology , 2002, Pharmacological Reviews.
[19] M. Lisanti,et al. Angiogenesis Activators and Inhibitors Differentially Regulate Caveolin-1 Expression and Caveolae Formation in Vascular Endothelial Cells , 1999, The Journal of Biological Chemistry.
[20] David S. Park,et al. Caveolin, Caveolae, and Endothelial Cell Function , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[21] J. Balligand,et al. Rosuvastatin Decreases Caveolin-1 and Improves Nitric Oxide–Dependent Heart Rate and Blood Pressure Variability in Apolipoprotein E−/− Mice In Vivo , 2003, Circulation.
[22] P. Huang,et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.
[23] L. Kobzik,et al. Endothelial Nitric Oxide Synthase Targeting to Caveolae , 1996, The Journal of Biological Chemistry.
[24] R. Sercombe,et al. Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat. , 2003, Cardiovascular research.
[25] T. Guarnieri,et al. Knockdown of caveolin-1 by antisense oligonucleotides impairs angiogenesis in vitro and in vivo. , 2000, Biochemical and biophysical research communications.
[26] P. Massart,et al. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. , 2002, American journal of physiology. Heart and circulatory physiology.
[27] P. Gallagher,et al. Increased numbers of caveolae in retinal endothelium and pericytes in hypertensive diabetic rats , 2001, Eye.
[28] R. Groszmann,et al. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. , 2003, Cancer cell.
[29] J. Ross,et al. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Isner,et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. , 1998, Circulation.
[31] D. Gingras,et al. Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. , 2003, Molecular biology of the cell.
[32] Yi Zhu,et al. Lipoprotein Promotes Caveolin-1 and Ras Translocation to Caveolae: Role of Cholesterol in Endothelial Signaling , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[33] T. Michel,et al. The Endothelial Nitric-oxide Synthase-Caveolin Regulatory Cycle* , 1998, The Journal of Biological Chemistry.
[34] J. Isner,et al. Age-dependent impairment of angiogenesis. , 1999, Circulation.
[35] Jean-Luc Balligand,et al. Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. , 2003, Cancer research.
[36] J. Balligand,et al. Hsp90 Ensures the Transition from the Early Ca2+-dependent to the Late Phosphorylation-dependent Activation of the Endothelial Nitric-oxide Synthase in Vascular Endothelial Growth Factor-exposed Endothelial Cells* , 2001, The Journal of Biological Chemistry.
[37] J. Isner,et al. Mouse model of angiogenesis. , 1998, The American journal of pathology.